CUE logo

Cue Biopharma, Inc.

CUE
Healthcare|Biotechnology|US
$18.73
+0.72 (+4.00%)
Tangible Book / Share
$0.36
Cash / Share
$2.74
Next Earnings Report
Nov 11, 2026
EPS est. -$2.24 · Revenue est. $1.0M
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Aug 12, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (3)

Jan 2027
Est. completion
P1Recurrent Glioblastoma
CUE-102 in Recurrent Glioblastoma
NCT06917885n=18
Oct 2027
Est. completion
P2Oropharyngeal Squamous Cell Carcinoma
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
NCT04852328n=30
Feb 2031
Est. completion
P2Head and Neck Squamous Cell Carcinoma
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
NCT07172256n=30

Recent Press Releases

Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
Sep 20, 2026 · GlobeNewsWire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE)
Aug 24, 2026 · PRNewsWire
Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 14, 2026 · GlobeNewsWire

SEC Filings (73)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Sep 21, 20268-KMaterial eventDocumentIndex
Aug 21, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 20, 2026EFFECTDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 12, 2026S-3Shelf registrationDocumentIndex
Aug 3, 20268-KMaterial eventDocumentIndex
Jul 22, 2026DDocumentIndex
Jul 10, 20268-KMaterial eventDocumentIndex
Jul 1, 2026EFFECTDocumentIndex
Jun 18, 2026S-3Shelf registrationDocumentIndex
Jun 17, 2026EFFECTDocumentIndex
Jun 3, 20268-KMaterial eventDocumentIndex
Jun 3, 2026S-8Employee stock planDocumentIndex
Jun 3, 2026S-3Shelf registrationDocumentIndex
Jun 2, 20268-KMaterial eventDocumentIndex
May 21, 2026DEF 14AProxy / shareholder voteDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 14, 2026DDocumentIndex
May 11, 2026PRE 14AProxy / shareholder voteDocumentIndex
May 1, 2026S-8Employee stock planDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 22, 20268-KMaterial eventDocumentIndex
Apr 13, 20268-KMaterial eventDocumentIndex
Apr 7, 20268-KMaterial eventDocumentIndex
Mar 31, 2026EFFECTDocumentIndex
Mar 27, 2026DEFA14AProxy / shareholder voteDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 16, 2026S-3Shelf registrationDocumentIndex
Mar 16, 2026ARSAnnual report to holdersDocumentIndex
Mar 16, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Mar 16, 202610-KAnnual reportDocumentIndex
Mar 6, 2026PRE 14AProxy / shareholder voteDocumentIndex
Feb 18, 20268-KMaterial eventDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Dec 19, 20258-KMaterial eventDocumentIndex